QR Code

The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease

Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previou...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Gurparneet Kaur Sohi, Naba Farooqui, Arjunmohan Mohan, Kamalnath Sankaran Rajagopalan, Li Xing, Xiang Y. Zhu, Kyra Jordan, James D. Krier, Ishran M. Saadiq, Hui Tang, LaTonya J. Hickson, Alfonso Eirin, Lilach O. Lerman, Sandra M. Herrmann
Hōputu: Artigo
Reo:Inglês
I whakaputaina: BMC 2024-06-01
Rangatū:Stem Cell Research & Therapy
Ngā marau:
Hypertensive kidney disease
Adipose mesenchymal stem cells
Hypoxia preconditioning
Angiogenesis
Senescence
Urunga tuihono:https://doi.org/10.1186/s13287-024-03778-1
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite